Background. Reports on long-term outcomes after endoscopic axillary lymph node dissection (ALND) of breast cancer patients are still lacking in the medical literature. The objective of this prospective study was to assess the oncological and functional outcomes in breast cancer patients after endoscopic ALND.
Introduction
Axillary lymph node staging represents an integral part of the surgical procedure in breast cancer patients. It provides important prognostic information and determines subsequent adjuvant therapy. Axillary clearance minimizes axillary recurrence rates [1] . Educational advertising, self-examination of the breast and screening mammography favour the detection of breast cancer at an early disease stage. Thus, the percentage of nodepositive patients who could benefit from routine axillary lymph node dissection (ALND) is constantly decreasing [2] . The growing population of node-negative patients should be spared a routine ALND with its considerable short-and long-term sequelae [3] . Two different minimally invasive methods aiming to define the pathological lymph node status with minimal morbidity were evaluated in the nineties. Before the sentinel lymph node (SLN) technique was initiated at our institution, we adopted the endoscopic ALND of level I and II. The SLN procedure was validated and established at our department in 1997 [4] . Although the SLN procedure as new axillary staging method in breast cancer patients has gained increasing importance over the past years, there are still surgeons and gynaecologists in Europe who perform level I and II ALND either by open or endoscopic approach. So far no long-term results after endoscopic ALND in breast cancer patients are available. The objective of the present prospective study was to evaluate long-term oncological and functional outcomes in breast cancer patients after endoscopic ALND.
Patients and methods
Between January 1996 and June 1998, 55 women with primary breast cancer stage I and II were prospectively enrolled (Table 1) . Exclusion criteria were: suspicious axillary lymph nodes and a tumour in the axillary tail in close vicinity to the axilla that was to be inflated. Written informed consent was obtained from all patients.
Technique of endoscopic ALND
The technique of endoscopic ALND has been described elsewhere [5] [6] [7] [8] . Briefly, the patients were placed in a supine position with the ipsilateral arm in a 90 degree abduction. The axillary fat pad was infiltrated with 250-450 ml of liposuction fluid, depending on the amount of axillary fat. The liposuction fluid consisted of 500 ml of 0.45% sodium chloride with 10 ml of 4% lidocaine and 5 mg adrenaline. During the ongoing axillary lipolysis process, tumourectomy was performed. Thereafter, the liposuction canula was introduced through an incision of 10-15 mm in the middle axillary line. Aspiration was achieved with a vacuum of 800 mbar. A first 10 mm trocar was then introduced through the existing incision. After insufflation of CO 2 gas with a pressure of 8 mmHg two additional 5 mm trocars were placed, one in the anterior and another in the posterior axillary line. The 25 degree angled 10 mm optic was used. The axillary lymph nodes of level I and II were dissected and removed through the 10 mm trocar after changing to a 5 mm optic. The optic, all trocars, and the endoscopic instruments were reusable and taken from the laparoscopy instrumentation box. No specific adaptations were necessary. At the end of the intervention the liposuction fluid was filtered through a gauze and the retrieved lymph nodes were sent separately for histopathology. All operations were carried out by one surgeon (F.H.)
Pathologic examination of lymph nodes
Excised and filtered lymph nodes were examined separately. Lymph nodes larger than 5 mm in diameter were bisected, whereas lymph nodes less than or equal to 5 mm in diameter were entirely submitted. Lymph nodes were formalin-fixed and embedded in paraffin for histologic analysis. Two sections were performed on the larger lymph nodes (one section on each half) whereas the smaller nodes were cut only once. The sections were stained with Haematoxylin & Eosin (H&E). No step sections or immunohistochemistry were performed.
Adjuvant therapy
After breast-conserving surgery patients received postoperative radiation therapy with 45 Gray over 5 weeks with an additional boost of 10 Gray to the tumour site, which was intraoperatively marked with a titanium clip. No radiation therapy was applied to the axilla. Systemic 
Postoperative follow-up
Postoperative follow-up consisted of a clinical examination of the breast and axilla every 4 months for the first 3 years, every 6 months in the following 2 years and yearly thereafter. Subjective criteria such as pain, numbness, and restrictions in daily life activities due to scarring or complaints in the arm were assessed. Objective criteria included the pre-and postoperative measurements of (1) range of motion in all directions of the shoulder according to the neutral zero crossing method; (2) the circumferences of both upper extremities 15 cm above and 10 cm below the olecranon and (3) the dexterity to bind an apron at the neck and the back. A deficit in range of motion greater than 20 degrees to standard values was considered pathologic. The diagnosis of lymphoedema was made if at least one of the following three criteria were present (subjective symptoms, objective findings, and asymmetric ipsi-and contralateral measurements). Symptoms like swelling and heaviness of the affected arm were considered diagnostic as well as clinical findings like indentation following skin depression, a loss of skin folds and asymmetry of the extremities. A 2 cm increase in one of the circumferences compared with the ipsilateral baseline measurements was considered pathologic. Furthermore, a 2 cm increase in circumference compared to the contralateral side was regarded as pathologic. For this purpose the handedness was noted, a 1 cm preoperative difference in favour of the dominant arm was considered normal. Consequently, values exceeding 1 cm were calculated to the postoperative measurement results.
At 24 months of follow-up a standardized questionnaire was sent to all patients assessing pain in the upper and lower arm, in the breast and chest wall, shoulder mobility, and restrictions in activities of daily living. Mammographies were performed annually. Breast ultrasound was only made for clarification of suspicious mammographic findings. Data were analyzed at 6 weeks after surgery (defined as early postoperative events) and during follow-up at a median of 24 and 71 months postoperatively.
Results
The patient characteristics are listed in Table 1 . Endoscopic ALND of level I and II was completed in 52 of 55 breast cancer patients (95%). Endoscopic ALND was converted to conventional open ALND in three patients due to bleeding of the thoracodorsal vein (n ¼ 1), to an exceedingly fatty axilla not enabling proper identification of important anatomical landmarks (n ¼ 1), and to fibrotic changes of the axillary fat pad after neoadjuvant chemotherapy (n ¼ 1). According to the intention-totreat principle these patients were also included in all analyses and remained tumour-free. Operating time for endoscopic ALND and removal of the primary tumour ranged from 95 to 240 min with a median of 135 min. We retrospectively compared the operating time of patients undergoing endoscopic axillary dissection to a group of 52 breast cancer patients with matched characteristics regarding tumour size and age receiving conventional ALND. All operations were performed by the same surgeon (F.H.) 1 year prior to starting the endoscopic axillary dissection. The operating time for conventional ALND and removal of the primary tumour ranged from 40 to 205 min with a median of 80 min whereas the endoscopic approach required on average 55 more minutes. This difference in operating time was statistically highly significant (p < 0.0001; Mann-Whitney U-test).
A median number of 13 (range: 5-25) axillary lymph nodes were removed during the 52 successfully performed endoscopic procedures. Additionally, an average of one lymph node (range 0-9) per patient was found in the filtered liposuction fluid. Sixteen of 52 patients (30.8%) had lymph node metastases. Four patients had metastatic nodes in the filtered fluid. In two of them these nodes were the only metastatic ones.
Systemic adjuvant treatment consisted of hormonal therapy in 30/52 patients (57.6%), of chemotherapy only in 13/52 patients (25%) and of combined treatment in 8/ 52 patients (15.4%). One patient (2%) did not receive any systemic therapy.
At 6 weeks postoperative complications occurred in 10/52 (19%) patients. Eight patients (15%) developed an axillary seroma and underwent one or several needle aspirations. Injury to the thoracodorsal nerve resulted in a persistent winged scapula in one patient (2%). A low grade infection of the axilla occurring in one patient during adjuvant chemotherapy was successfully treated with antibiotics (2%). The patients were discharged after a median of 5.6 days (1-16 days) .
Three patients were lost to follow-up who were excluded from the analyses due to lack of information. Eight patients died at a median of 34.0 months (range 10.6 to 67.4 months) post surgery. Death was related to metastatic disease in four patients (bone, liver, brain and lung), two of whom were node-positive at the time of surgery, another patient showed a high grade pT2 tumour and the last was a premenopausal woman with a pT2 G2 carcinoma. One patient died of leukaemia, and three deaths were due to other, non-oncological causes. Furthermore, two patients developed bone metastases, one of them being initially node-positive. Local breast recurrence occurred in one patient (1/52, 2%).
In two patients histologically confirmed port-site metastases were detected at 24 and 49 months after endoscopic ALND, respectively (2/52, 4%). Diagnosis was histologically confirmed after excision of the affected axillary skin. One of these postmenopausal women was node positive at the time of the initial operation (9 of 17 positive lymph nodes) staged as a pT2G2 invasive ductal carcinoma. After excision of the port-site metastasis at 24 months, distant metastatic disease to the liver occurred. The patient died one year later. In the second patient with pT2G3 invasive lobular carcinoma, all 11 endoscopically removed lymph nodes were free of metastases. Simultaneously with the portsite metastasis this patient developed the only axillary recurrence (1/52, 2%) found in our study population. The recurrence was surgically removed. Three years later, the patient is still alive and without evidence of recurrent local or metastatic disease.
The questionnaire was filled out by 52 patients at a median of 24 months (range 7-37 months) postoperatively. On a scale between 1 (worst) and 10 (excellent) the patients noted median values for pain in the upper and lower arm, pain in breast and chest wall, shoulder mobility, and restrictions in activities of daily living between 9.2 and 9.9 ( Table 2) . At physical examination at the same time point two patients suffered from restricted shoulder mobility with an anteversion deficit of 20 degrees and abduction deficit of 30 degrees. Twelve of 52 patients (23%) indicated shoulder pain at abduction and anteversion movement and 9/52 patients (17%) superficial pain in the dorsomedial skin area of the affected upper arm. Three patients (6%) complained of numbness of the upper arm. No lymphoedema was detected at that stage (Table 3) .
Median follow-up for the 52 patients was 71.9 months ranging from 11 to 96 months. Other than noted in the questionnaire no relevant numbness or hypertrophic scar were observed on clinical work-up. Shoulder pain (n ¼ 12) and pain in the upper arm (n ¼ 9), which were present at the first evaluation after a median of 24 months postoperatively, disappeared completely during further follow-up. No increase in functional restrictions of the shoulder regarding range of motion was noticed. At the last follow-up examination three patients (6%) had developed lymphoedema with an increase in circumference of 3-4 cm in the upper and/ or lower arm. None of the three patients suffered from recurrent axillary or distant disease, none complained of chronic pain or restriction in range of motion and in daily life. The number of lymph nodes removed in these patients were 12, 16 and 21, respectively. Two of these patients were node-positive at the time of operation with 1/21 and 3/12 positive lymph nodes, respectively (Table 3) .
Discussion
The present investigation with long-term follow-up after endoscopic ALND -the first one reported in the literature -reveals minor morbidity, good functional and cosmetic results after endoscopic ALND. The endoscopic procedure shows a low axillary recurrence rate as one can expect after open level I and II ALND. But the endoscopic ALND carries a risk of port-site metastases. The clinical and prognostic impact of port-site metastases is unknown.
Our study provides compelling evidence that endoscopic ALND is advantageous regarding long-term functional results such as shoulder mobility and chronic pain when compared with conventional ALND [10] . The occurrence of moderate lymphoedema in 6% in the present investigation is lower than in the majority of investigations assessing the morbidity of conventional ALND. Indeed, the incidences of lymphoedema after open axillary dissection are described between 5 and 25% [1, [11] [12] [13] [14] [15] [16] . Although there are generally accepted criteria but not well-established guidelines to diagnose lymphoedema using circumferential measurements, there are no universally applied methods to quantitatively define lymphoedema and no standard degree of enlargement or consensus, what constitutes lymphoedema, thereby complicating interpretation of the literature [17] . There are reports citing that a greater than 2 cm difference from baseline (preoperative) measurements identifies lymphoedema [18] . On the other hand girth measurements do not always correlate with symptoms or quality of life [19] . A combination of symptom assessment and limb measurement may provide the best clinical assessment data for identifying changes associated with post-breast cancer lymphoedema [20, 21] . In a retrospective study from our institution including 390 breast cancer patients undergoing ALND lymphoedema of the upper and lower arm were found in 13.2 and 8.4%, respectively, after a median follow-up of 62 months [10] . In the afore-mentioned investigation, numbness was seen in 28%, hypertrophic scar in 17%, and shoulder pain in 15% of all patients, clearly more frequently than in the present study. Oncological safety might, however, be compromised as port-site metastases occurred in two patients (4%), one of whom suffered concomitantly from an axillary recurrence (2%). Current medical literature describes a similar axillary recurrence rate between 0 and 2% after open ALND [22] . In the above mentioned study from our institution an axillary recurrence rate of 1.3% after standard ALND of level l and II was observed [10] . Skin implantation metastasis after open ALND is an unknown adverse event and has never been published before. The prognostic significance of port-site metastases after endoscopic ALND for breast cancer is unclear. Port-site metastases are a known phenomenon in laparoscopic surgery for abdominal malignancies. Wexner reported an incidence of 4% in laparoscopic colorectal surgery for cancer [23] . Port-site metastases correlated with shortened survival in ovarian and gallbladder cancer [24] . Endoscopic ALND offers several advantages compared with conventional ALND. It provides an excellent view of the various important anatomical structures, Suzanne et al. [5] Brun et al. [26] Kamprath et al. [28] Kuehn et al.
[ [25, 27, 32] . Moreover, the significantly increased operating time, in our investigation almost 1 h, further contributes to higher costs. Material expenses in our group of patients were very low because reusable trocars and already available laparoscopic instruments were used and no specific adaptations were necessary. Finally, and most importantly, endoscopic ALND ignores the general surgical oncological principle of en-bloc resection of potentially tumour-involved lymph nodes. The port-site metastases in two of our patientsthe first description in the literature after endoscopic ALND -could result from violation of this principle. In other published series with shorter follow-up times (median follow-up shorter than or equal to 18 months) axillary recurrences after endoscopic ALND occurred between 0% [32] and 10% [5, 26, 27, 32] (Table 4 ). The two axillary failures published in the paper of Salvat et al. were both observed in patients with primarily extensive lymph node involvement [32] .
Conclusion
Endoscopic ALND is associated with minor morbidity, good functional and cosmetic results. However, the endoscopic procedure carries the risk of port-site metastases. The axillary recurrence rate is similar to the results after conventional open ALND. Based on previous assessments of our SLN data and the current literature, the SLN biopsy is a more adapted, less invasive technique and should be considered the preferred axillary staging procedure.
